Skip to main content
Market intelligence
HEPAHealthcare

Hepion Pharmaceuticals Inc insider activity

In the last 90 days, 5 corporate insiders purchased $825,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$825,000
Corporate buyers
5
Latest transaction
Aug 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 3, 2026Gary S. Stetz IiCorporate insiderOpen Market Purchase500,000$0.05$25,000
Aug 3, 2026Gary S. StetzInterim CEOOpen Market Purchase2,000,000$0.05$100,000
Aug 3, 2026Michael J. PurcellCorporate insiderOpen Market Purchase2,000,000$0.05$100,000